Abstract
Technologic innovations, including the development of improved sampling devices, liquid-based collection systems, and computer-assisted screening, have revolutionized cervical cytology. Biologic discoveries in upcoming years promise to transform our understanding of the pathogenesis of cervical neoplasia, leading to another quantum leap in our approach to screening and prevention. This review summarizes the opportunities and challenges that recent and anticipated advances in pathology present for epidemiologic research.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Adenocarcinoma / diagnosis
-
Colposcopy
-
DNA, Viral / isolation & purification
-
Female
-
Humans
-
Mass Screening / methods*
-
Mass Screening / trends*
-
Papillomaviridae* / genetics
-
Papillomaviridae* / isolation & purification
-
Papillomavirus Infections / diagnosis
-
Triage
-
Tumor Virus Infections / diagnosis
-
Uterine Cervical Diseases / diagnosis*
-
Uterine Cervical Diseases / pathology
-
Uterine Cervical Dysplasia / diagnosis
-
Uterine Cervical Neoplasms / diagnosis